New Immune-Targeting drug shows promise for tough autoimmune cases
NCT ID NCT06888960
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 31 times
Summary
This early-stage study tests the safety of a new drug called CC312 in 18 adults with autoimmune diseases like lupus, rheumatoid arthritis, and scleroderma that have not responded to standard treatments. CC312 works by helping the body's immune cells find and attack faulty B cells, similar to CAR-T therapy. The study uses a low starting dose to reduce the risk of side effects like cytokine release syndrome, then increases the dose to find the safest and most effective level.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS (SSC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
RECRUITINGTianjin, China, 300030, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.